We didnt do it for the capital, and we were very selective about the celebrities and influencers who approached us, said Durana Elmi, co-founder and COO
Optimize your diet alongside the medication Tirzepatide suppresses appetite, but what you eat during that reduced intake matters enormously
Everyones body is different, meaning each body may respond better or worse to either of these medications
CKD prevalence is substantial among people with T2D (up to ~ 50%), and obesity is estimated to increase lifetime risk of CKD by 25% [5, 6]
Study Strengths & Limitations Strengths: Large, international, double-blind RCT with adjudicated endpoints Comprehensive, repeated adiposity measures using standardised protocols Sophisticated statistical handling including multiple imputation models for missing data Pre-specified analysis with clear hypotheses Limitations: Predominantly White (77%) and male (63%) cohortgeneralisability to other populations requires confirmation Industry-funded (Novo Nordisk), though with independent academic oversight Post-randomisation analyses of weight/waist changes are observational and cannot prove causation The paradoxical association in placebo between weight loss and increased MACE suggests unintentional weight loss from comorbiditya key confounder The Bottom Line for Clinicians Semaglutide provides robust cardiovascular protection in patients with obesity and established CVD, independent of baseline adiposity and largely independent of weight-loss magnitude
Lip filler shapes should be chosen around your natural anatomy
